Total Valuation
NuGen Medical Devices Inc has a market cap or net worth of C$3.41M. The enterprise value is C$22.46M.
Market CapC$3.41M
Enterprise ValueC$22.46M
Share Statistics
NuGen Medical Devices Inc has 227,035,680 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding227,035,680
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
NuGen Medical Devices Inc’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count15
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of NuGen Medical Devices Inc is ―. NuGen Medical Devices Inc’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to FCF0.00
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, NuGen Medical Devices Inc had revenue of ― and earned -9.36M in profits. Earnings per share was ―.
Revenue―
Gross Profit164.84K
Operating Income-8.05M
Pretax Income―
Net Income-9.36M
EBITDA-7.29M
Earnings Per Share (EPS)―
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
NuGen Medical Devices Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.34
52-Week Price Change-62.50%
50-Day Moving Average0.02
200-Day Moving Average0.02
Relative Strength Index (RSI)45.61
Average Volume (3m)0.00
Important Dates
NuGen Medical Devices Inc upcoming earnings date is Dec 2, 2026, TBA (Not Confirmed).
Last Earnings DateAug 31, 2026
Next Earnings DateDec 2, 2026
Ex-Dividend Date―
Financial Position
NuGen Medical Devices Inc as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, NuGen Medical Devices Inc has paid ― in taxes.
Income Tax―
Effective Tax Rate―
Enterprise Valuation
NuGen Medical Devices Inc EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
NuGen Medical Devices Inc has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt―
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for NuGen Medical Devices Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-86.31%
EPS Growth Forecast-190.48%